194 related articles for article (PubMed ID: 27256152)
1. Local administration of platelet-derived growth factor B (PDGFB) improves follicular development and ovarian angiogenesis in a rat model of Polycystic Ovary Syndrome.
Di Pietro M; Scotti L; Irusta G; Tesone M; Parborell F; Abramovich D
Mol Cell Endocrinol; 2016 Sep; 433():47-55. PubMed ID: 27256152
[TBL] [Abstract][Full Text] [Related]
2. Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model.
Di Pietro M; Parborell F; Irusta G; Pascuali N; Bas D; Bianchi MS; Tesone M; Abramovich D
Endocrinology; 2015 Apr; 156(4):1453-63. PubMed ID: 25590243
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M
Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor BB and DD and angiopoietin1 are altered in follicular fluid from polycystic ovary syndrome patients.
Scotti L; Parborell F; Irusta G; De Zuñiga I; Bisioli C; Pettorossi H; Tesone M; Abramovich D
Mol Reprod Dev; 2014 Aug; 81(8):748-56. PubMed ID: 24889290
[TBL] [Abstract][Full Text] [Related]
5. The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome.
Tal R; Seifer DB; Arici A
Semin Reprod Med; 2015 May; 33(3):195-207. PubMed ID: 26036901
[TBL] [Abstract][Full Text] [Related]
6. Ovarian angiogenesis in polycystic ovary syndrome.
Di Pietro M; Pascuali N; Parborell F; Abramovich D
Reproduction; 2018 May; 155(5):R199-R209. PubMed ID: 29386378
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor B restores vascular barrier integrity and diminishes permeability in ovarian hyperstimulation syndrome.
Pascuali N; Scotti L; Oubiña G; de Zúñiga I; Gomez Peña M; Pomilio C; Saravia F; Tesone M; Abramovich D; Parborell F
Mol Hum Reprod; 2020 Aug; 26(8):585-600. PubMed ID: 32467982
[TBL] [Abstract][Full Text] [Related]
9. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.
Palomba S; Falbo A; Russo T; Orio F; Tolino A; Zullo F
Hum Reprod; 2010 Apr; 25(4):1005-13. PubMed ID: 20106839
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
[TBL] [Abstract][Full Text] [Related]
11. Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment.
Gómez R; Ferrero H; Delgado-Rosas F; Gaytan M; Morales C; Zimmermann RC; Simón C; Gaytan F; Pellicer A
J Clin Endocrinol Metab; 2011 Aug; 96(8):2484-92. PubMed ID: 21646367
[TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone and polycystic ovary syndrome.
Bhide P; Homburg R
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():38-45. PubMed ID: 27103234
[TBL] [Abstract][Full Text] [Related]
13. The effect of cabergoline on folicular microenviroment profile in patients with high risk of OHSS.
Guvendag Guven ES; Dilbaz S; Duraker R; Mentese A; Cinar O; Ozdegirmenci O
Gynecol Endocrinol; 2013 Aug; 29(8):749-53. PubMed ID: 23741965
[TBL] [Abstract][Full Text] [Related]
14. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
Du DF; Li XL; Fang F; Du MR
Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
[TBL] [Abstract][Full Text] [Related]
15. Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome.
Zhang C; Ma J; Wang W; Sun Y; Sun K
Hum Reprod; 2018 Nov; 33(11):2096-2106. PubMed ID: 30272163
[TBL] [Abstract][Full Text] [Related]
16. HDAC5 inhibits ovarian angiogenesis in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.
Wang Y; Wang Y; Chen Y; Gao Q; Hou L; Feng X
Folia Histochem Cytobiol; 2022; 60(3):260-270. PubMed ID: 36124413
[TBL] [Abstract][Full Text] [Related]
17. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.
Das M; Gillott DJ; Saridogan E; Djahanbakhch O
Hum Reprod; 2008 Sep; 23(9):2122-6. PubMed ID: 18550512
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries.
Ferrara N; Frantz G; LeCouter J; Dillard-Telm L; Pham T; Draksharapu A; Giordano T; Peale F
Am J Pathol; 2003 Jun; 162(6):1881-93. PubMed ID: 12759245
[TBL] [Abstract][Full Text] [Related]
19. Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome.
Ergenoglu M; Yildirim N; Yildirim AG; Yeniel O; Erbas O; Yavasoglu A; Taskiran D; Karadadas N
Reprod Sci; 2015 Aug; 22(8):942-7. PubMed ID: 25667201
[TBL] [Abstract][Full Text] [Related]
20. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
